BINDU JOSE: Open Payments
NPI 1306361290 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 19 payments from 7 companies in 2025. Trend: 2023 $599 · 2024 $610 · 2025 $568
Food & beverage: $392Education: $175
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 1 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $21 |
Products named: CAPLYTA, INVEGA SUSTENNA, INGREZZA, COBENFY, AUSTEDO XR, FANAPT, UZEDY, LYBALVI.
Industry payments across AZ — which companies pay providers there.
